StockData
TFXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

TELEFLEX INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$129.68−0.75 (-0.58%)

Close on Oct 19, 2026

Market cap
$5.66B
P/E (TTM)
–
Dividend yield
1.05%

Earnings

Next report expected Nov 5, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 6, 2026Before market open$570.30M$0.96$1.76
Q1 FY2026
Ended Mar 31, 2026
May 7, 2026Before market open$548.30M$-0.11$1.39
Q4 FY2025
Ended Dec 31, 2025
Jan 8, 2026Before market open–––
Q3 FY2025
Ended Sep 28, 2025
Nov 6, 2025Before market open$913.00M$-9.24$3.67
Q2 FY2025
Ended Jun 29, 2025
Jul 31, 2025Before market open$780.90M$2.77$3.73
Q1 FY2025
Ended Mar 30, 2025
May 1, 2025Before market open$700.70M$2.07$2.91
Q4 FY2024
Ended Dec 31, 2024
Feb 27, 2025Before market open$795.40M$-2.95$3.89
Q3 FY2024
Ended Sep 29, 2024
Oct 31, 2024Before market open$764.40M$2.36$3.49
Q2 FY2024
Ended Jun 30, 2024
Aug 1, 2024Before market open–––
Q1 FY2024
Ended Mar 31, 2024
May 2, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 22, 2024Before market open–––

Company guidance

Outlook given with results on Aug 6, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Adjusted diluted EPS from continuing operationsnon-GAAP2026$6.90 to $7.20Raised
GAAP EPS from continuing operationsGAAP2026$2.54 to $2.84Lowered
adjusted operating marginnon-GAAP202619%New
GAAP revenue growthGAAP202613.4% to 14.4% growthLowered
pro forma adjusted constant currency revenue growthnon-GAAP20263.5% to 4.5% growthLowered

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Teleflex filed with the SEC